ALK’s house dust mite tablet (ACARIZAX®) now recommended by NICE for use in the UK health system
ALK (ALKB:DC / OMX: ALK B / AKBLF) today announced that the National Institute for Health and Care Excellence (NICE) has recommended the use of ACARIZAX® for the treatment of persistent, moderate to ...
The Pharma Letter20h
First-in-class treatment approved by NICE for allergic rhinitis
UK health technology assessor the National Institute for Health and Care Excellence (NICE) has recommended Acarizax (12 ...
Could RFK Jr be a disruptor and reformer at HHS?
RFK Jr's overarching philosophy regarding MAHA is sound. As a society, we weigh too much, are too sedentary and are exposed ...
verywellhealth12h
Can You Outgrow Asthma?
The short answer is no, you cannot outgrow asthma, but your symptoms may be less severe. Learn when asthma goes into ...
Biotech Alert: Searches spiking for these stocks today
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
The 7 Types of Eczema: Symptoms And Causes
Atopic dermatitis is one of the most common types of eczema. Signs may include inflamed skin, rash, itchiness and excessive dryness. It may also include bumps and swollen skin that may ooze. It ...
Rolling Out17h
7 shocking facts about the rising allergy epidemic
Discover the alarming rise in allergy cases, understand the science behind immune responses, and learn effective management ...
The Healthy on MSN19h
What Is Allergy Immunotherapy, and Does It Work?
Allergy medications not doing the job this season? Experts explain why allergy immunotherapy may be the newest answer to ...
The Healthy on MSN17h
When Exactly Is Allergy Season?
Not sure when those pesky seasonal allergies are going to hit? An allergist explains when you can expect allergy season to ...
IRLAB Reports Positive Topline Results from Phase I Study with IRL757 in Healthy Older Adults
ANNOUNCEMENT FOR EUROPEAN MEDICAL & PHARMACEUTICAL TRADE MEDIA AND EUROPEAN FINANCIAL MEDIA ONLY. GOTHENBURG, SWEDEN / ACCESS Newswire / January 31, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) ...
New treatments offer hope for one skin condition that often worsens in winter
As temperatures drop, many people experience dry, red, and itchy skin, a condition that often worsens in winter.
New Atlas4h
FDA approves new class of painkiller – the first in more than 20 years
The US Food and Drug Administration has approved the use of a novel painkiller as an effective treatment for short-term ...